Japanese type 1 diabetic syndrome

Diabetes/Metabolism Reviews

Volumn 12, Issue 3, 1996, Pages 175-194

  Kawasaki, Eiji ^a,b   Nagataki, Shigenobu ^a  

^a NAGASAKI UNIVERSITY   (Japan)

^b UNIVERSITY OF COLORADO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HLA ANTIGEN; HLA ANTIGEN CLASS 2;

ADOLESCENT; ADULT; AUTOIMMUNITY; CHILD; CONTROLLED STUDY; DISEASE PREDISPOSITION; FEMALE; HUMAN; INFANT; INSULIN DEPENDENT DIABETES MELLITUS; JAPAN; MAJOR CLINICAL STUDY; MALE; NEWBORN; PRIORITY JOURNAL; REVIEW;

CHILD; DIABETES MELLITUS, TYPE 1; HUMANS; JAPAN;

EID: 0029850857     PISSN: 07424221     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1099-0895(199610)12:3<175::AID-DMR163>3.0.CO;2-L     Document Type: Review

References (168)

1. National Diabetes Data Group: Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance. Diabetes 28: 1039-1057, 1979.
2. WHO Expert Committee on Diabetes Mellitus: Second report. WHO Tech Rep Ser 646: 1-80, 1980.
3. Diabetes Mellitus. Report of WHO study group: WHO Tech Rep Ser 727: 1-113, 1985.
4. LaPorte RE, Tajima N, Akerblom HK, Berlin BA, Brosseau J, Christy M, Drash AL, Fishbein H, Green A, Hamman R, Harris M, King H, Laron Z, and Neil A: Geographic differences in the risk of insulin-dependent diabetes mellitus: the importance of registries. Diabetes Care 8 (Suppl 1): 101-107, 1985.
5. Diabetes Epidemiology Research International Group: Geographic patterns of childhood insulin-dependent diabetes mellitus. Diabetes 37: 1113-1119, 1988.
6. Tuomilehto J, Virtala E, Karvonen M, Lounamaa R, Pitkäniemi J, Reunanen A, Tuomilehto-Wolf E, Toivanen L, and the DIME Study Group: Increase in incidence of insulin-dependent diabetes mellitus among children in Finland. Int J Epidemiol 24: 984-992, 1995.
7. Kitagawa T, Fujita H, Hibi I, Aagenaes O, Laron O, LaPorte RE, Tajima N, and Drash AL: A comparative study on the epidemiology of IDDM between Japan, Norway, Israel and the United States. Acta Pediatr Jpn 226: 275-281, 1984.
8. Urakami T, Miyamoto Y, Fujita H, Kitagawa T: Type 1 (insulin-dependent) diabetes in Japanese children is not a uniform disease. Diabetologia 32: 312-315, 1989.
9. Hibi I, Tanae A, Isshiki H, Kitagawa T, Tsuchiya H, Maruyama H, and Matsuura N: Juvenile type (insulin-dependent type) diabetes under 18 years of age at onset: current status in Japan. Clin Endocrinol 30: 981-991, 1982 (in Japanese).
10. Japan IDDM Epidemiology Study Group: Lack of regional variation in IDDM risk in Japan. Diabetes Care 16: 796-800, 1993.
11. Matsuura N: Epidemiology of juvenile-onset IDDM in Hokkaido. In Report of Diabetes Study Group. Ministry of Welfare and Health, Government of Japan, 1994, pp 15-19 (in Japanese).
12. LaPorte RE, Matsushima M, and Chang YF: Prevalence and incidence of insulin-dependent diabetes. In Diabetes in America, 2nd edn, National Diabetes Data Group (Ed). NIH, Bethesda, 1995, pp 37-46.
13. Sasaki A, and Okamoto N: Epidemiology of childhood diabetes in Osaka district, Japan, using the documents from the medical benefits system specific for childhood diabetes. Diabetes Res Clin Pract 18: 191-196, 1992.
14. Kitagawa T, Owada M, Urakami T, and Tajima N: Epidemiology of type 1 (insulin-dependent) and type 2 (non-insulin-dependent) diabetes mellitus in Japanese children. Diabetes Res Clin Pract 24 (Suppl): S7-S13, 1994.
15. Diabetes Epidemiology Research International Group: Secular trends in incidence of childhood IDDM in 10 countries. Diabetes 39: 858-864, 1990.
16. Joner G, and Sovik O: Incidence, age at onset and seasonal variation of diabetes mellitus in Norwegian children 1973-1977. Acta Pediatr Scand 70: 329-335, 1981.
17. Patterson CC, Thorogood M, Smith PG, Heasman MA, Clarke JA, and Mann JI: Epidemiology of type 1 (insulin-dependent) diabetes in Scotland 1968-1976: evidence of an increasing incidence. Diabetologia 24: 238-246, 1983.
18. Green A, and Andersen PK: Epidemiological studies of diabetes mellitus in Denmark: clinical characteristics and incidence of diabetes among males aged 0-19 years. Diabetologia 25: 226-230, 1983.
19. Dokheel TM for the Pittsburgh Diabetes Epidemiology Research Group: An epidemic of childhood diabetes in the United States? Evidence from Allegheny Country, PA. Diabetes Care 16: 1606-1611, 1993.
20. Davies JL, Kawaguchi Y, Bennett ST, Copeman JB, Cordell HJ, Pritchard LE, Reed PW, Gough SCL, Jenkins SC, Palmer SM, Balfour KM, Rowe BR, Farrall M, Barnett AH, Bain SC, and Todd JA: A genome-wide search for human type 1 diabetes susceptibility genes. Nature 371: 130-136, 1994.
21. Bennett ST, Lucassen AM, Gough SCL, Powell EE, Undlien DE, Pritchard LE, Merriman ME, Kawaguchi Y, Dronsfield MJ, Pociot F, Nerup J, Bouzekri N, Cambon-Thomsen A, Rønningen KS, Barnett AH, Bain SC, and Todd JA: Susceptibility to human type 1 diabetes at IDDM2 is determined by tandem repeat variation at the insulin gene minisatellite locus. Nature Genet 9: 284-292, 1995.
22. Field LL, Tobias R, Magnus T: A locus on chromosome 15q26 (IDDM3) produces susceptibility to insulin-dependent diabetes mellitus. Nature Genet 8: 189-194, 1994.
23. Copeman JB, Cucca F, Hearne CM, Cornall RJ, Reed PW, Rønningen KS, Undlien DE, Nistico L, Buzzetti R, Tosi R, Pociot F, Nerup J, Cornelis F, Barnett AH, Bain SC, and Todd JA: Linkage disequilibrium mapping of a type 1 diabetes susceptibility gene (IDDM7) to chromosome 2q31-q33. Nature Genet 9: 80-85, 1995.
24. Luo DF, Bui MM, Muir A, Maclaren NK, Thomson G, and She JX: Affected-sib pair mapping of a novel susceptibility gene to insulin-dependent diabetes mellitus (IDDM8) on chromosome 6q25-q27. Am J Hum Genet 57: 911-919, 1995.
25. Nerup J, Platz P, Ortved Andersen O, Christy M, Lyngsoe J, Poulsen JE, Ryder L, Staub Nielsen L, Thomsen M, and Svejgaard A: HLA antigens and diabetes mellitus. Lancet ii: 864-866, 1974.
26. Nerup J, Chatelineau C, Seignalet J, and Thomsen M: HLA and endocrine diseases. In HLA and Disease, Dausset J, and Svejgaard A (Eds). Munksgaard, Copenhagen, 1977, pp 149-167.
27. Thomsen M, Platz P, Andersen O, Christy M, Lyngsoe J, Nerup J, Rasmussen K, Ryder LP, Staub Nielsen L, and Svejgaard A: MLC typing in juvenile diabetes mellitus and Idiopatic Addison's disease. Transplant Rev 22: 125-147, 1975.
28. Bodmer JG, Pickbourne P, and Richards S: La serology. In Histocompatibility Testing 1977, Bodmer WF (Ed). Munskgaard, Copenhagen, 1978, pp 35-84.
29. de Moerloose P, Jeannet M, Bally C, Raffoux C, Pointel JP, and Sizonenko P: HLA and DRw antigens in insulin-dependent diabetes. Br Med J i: 823-824, 1978.
30. Korman AJ, Boss JM, Spies T, Sorrentino R, Okada K, and Strominger JL: Genetic complexity and expression of human class II histocompatibility antigens. Immunol Rev 85: 45-78, 1985.
31. Cohen-Haguenauer O, Robbins E, Massart C, Busson M, Deschamps I, Hors J, Lalouel J, Dausset J, and Cohen D: A systematic study of HLA class II-β DNA restriction fragments in insulin-dependent diabetes mellitus. Proc Natl Acad Sci USA 82: 3335-3339, 1985.
32. Tosi R, Vela M, Adorno D, Longo A, Papola F, Maccarone D, Centis D, Tanigaki N, Raponi MP, Candela A, Campea L, Orsini M, and Ferrara GB: Radioimmunoassay typing give a more precise definition of the HLA association of type I (insulin-dependent) diabetes. Diabetologia 29: 430-433, 1986.
33. + seropositive juvenile rheumatoid arthritis. J Exp Med 164: 345-350, 1986.
34. Festenstein H, Awad J, Hitman GA, Cutbush S, Groves AV, Cassell P, Ollier W, and Sachs JA: New HLA DNA polymorphisms associated with autoimmune diseases. Nature 322: 64-67, 1986.
35. Wakisaka A, Aizawa M, Matsuura N, Nakagawa S, Nakayama E, Itakura K, Okuno A, and Wagatsuma Y: HLA and juvenile diabetes mellitus in the Japanese. Lancet ii: 970, 1976.
36. Okimoto K, Juji T, Ishiba S, Maruyama H, Tohy- ama H, and Kosaka K: HLA-Bw54 (Bw22-J, J-1) antigen in juvenile onset diabetes mellitus in Japan. Tissue Antigens 11: 418-422, 1978.
37. Moriuchi J, Katagiri M, Wakisaka A, Matsuura N, Maruyama N, Ikeda H, Aizawa M, and Itakura L: Association of B cell alloantigen with juvenile onset diabetes mellitus in the Japanese. Hum Immunol 4: 357-362, 1980.
38. Higa S: A search for heterogeneity in insulin-dependent diabetes mellitus (IDDM): HLA and autoimmune studies among Japanese. Jpn J Constitutional Med 54: 92-103, 1990 (in Japanese).
39. Schernthaner G: The relationship between clinical, immunological and genetic factors in insulin-dependent diabetes. In The Genetics of Diabetes Mellitus, Kobberling J, and Tattersall R (Eds). Academic Press, New York, 1982, p 99.
40. Farid NR, Larsen B, Payne R, Noel EP, and Sampson L: Polyglandular autoimmune disease and HLA. Tissue Antigens 16: 23-29, 1980.
41. Kida K, Mimura G, Kobayashi T, Nakamura K, Sonoda S, Inouye H, and Tsuji K: Immunogenetic heterogeneity in type 1 (insulin-dependent) diabetes among Japanese-HLA antigen and organ-specific autoantibodies. Diabetologia 32: 34-39, 1989.
42. Chikuba N, Akazawa S, Yamaguchi Y, Kawasaki E, Takino H, Takao Y, Maeda Y, Okuno S, Yamamoto H, Yokota A, Yoshimoto M, and Nagataki S: Type 1 (insulin-dependent) diabetes mellitus with coexisting autoimmune thyroid disease in Japan. Intern Med 31: 1076-1080, 1992.
43. Todd JA, Bell JI, and McDevitt HO: HLA-DQB gene contributes to susceptibility and resistance to insulin-dependent diabetes mellitus. Nature 329: 599-604, 1987.
44. Dorman JS, LaPorte RE, Stone RA, and Trucco M: Worldwide differences in the incidence of type 1 diabetes are associated with amino-acid variation at position 57 of the HLA-DQβ chain. Proc Natl Acad Sci USA 87: 7370-7374, 1990.
45. Yamagata K, Nakajima H, Hanafusa T, Noguchi T, Miyazaki A, Miyagawa J, Sada M, Amemiya H, Tanaka T, Kono N, and Tarui S: Aspartic acid at position 57 of DQβ chain does not protect against type 1 (insulin-dependent) diabetes mellitus in Japanese subjects. Diabetologia 32: 762-764, 1989.
46. Awata T, Kuzuya T, Matsuda A, Iwamoto Y, Kanazawa Y, Okuyama M, and Juji T: High frequency of aspartic acid at position 57 of HLA-DQβ chain in Japanese IDDM patients and non-diabetic subjects. Diabetes 39: 266-269, 1990.
47. Ikegami H, Tahara Y, Cha T, Yamato E, Ogihara T, Noma Y, and Shima K: Aspartic acid at position 57 of the HLA-β chain is not protective against insulin-dependent diabetes mellitus in Japanese people. J Autoimmun 3: 167-174, 1990.
48. Aparicio JMR, Wakisaka A, Takada A, Matsuura N, and Aisawa M: HLA-DQ system and insulin-dependent diabetes mellitus in Japanese: does it contribute to the development of IDDM as it does in Caucasian? Immunogenetics 28: 240-246, 1988.
49. Awata T, Hagura R, Urakami T, and Kanazawa Y: Age-dependent HLA genetic heterogeneity of IDDM in Japanese patients. Diabetologia 38: 748-749, 1995.
50. Awata T, and Kanazawa Y: Genetic markers for insulin-dependent diabetes mellitus in Japanese. Diabetes Res Clin Pract 24 (Suppl): S83-S87, 1994.
51. Awata T, Kuzuya T, Matsuda A, Iwamoto Y, and Kanazawa Y: Genetic analysis of HLA class II alleles and susceptibility to type 1 (insulin-dependent) diabetes mellitus in Japanese subjects. Diabetologia 35: 419-424, 1992.
52. Hamaguchi K, Kimura A, Dong R, Noda N, Horita M, Okeda T, Ono J, Takaki R, and Sasazuki T: Analysis of HLA class II genes of Japanese type I diabetic patients by PCR-SSOP method. Mol Diabetol 3: 123-129, 1992 (in Japanese).
53. Khalil I, D'Auriol L, Gobet M, Morin L, Lepage V, Deschamps I, Park MS, Degos L, Galibert F, and Hors J: A combination of HLA-DQB Asp 57 negative and HLA-DQA Arg 52 confers susceptibility to IDDM. J Clin Invest 85: 1315-1319, 1990.
54. Rønningen KS, Spurkland A, Iwe T, Vartdel F, and Thorsby E: Distribution of HLA-DRB1, - DQA1 and DQB1 alleles and DQA1-DQB1 genotypes among Norwegian patients with insulin-dependent diabetes mellitus. Tissue Antigens 37: 105-111, 1991.
55. Todd JA, Mijovic C, Fletcher J, Jenkins D, Bradwell AR, and Barnett AH: Identification of susceptibility loci for insulin-dependent diabetes mellitus by trans-racial gene mapping. Nature 338: 587-589, 1989.
56. Mijovic CH, Jenkins P, Jacobs KH, Penny MA, Fletcher JA, and Barnett AH: HLA-DQA1 and - DQB1 alleles associated with genetic susceptibility to IDDM in a black population. Diabetes 40: 748-753, 1991.
57. Ikegami H, Kawaguchi Y, Yamato E, Kuwata S, Tokunaga K, Noma Y, Shima K, and Ogihara T: Analysis by the polymerase chain reaction of histocompatibility leucocyte antigen-DR9-linked susceptibility to insulin-dependent diabetes mellitus. J Clin Endocrinol Metabol 75: 1381-1385, 1992.
58. Bell GI, Karam JH, and Rutter WJ: Polymorphic DNA region adjacent to the 5′ end of the human insulin gene. Proc Natl Acad Sci USA 78: 5759-5763, 1981.
59. Rotwein P, Chyn R, Chirgwin J, Cordell B, Goodman HM, and Permut MA: Polymorphism in the 5′ flanking region of the human insulin gene and its possible relation to type 2 diabetes. Science 213: 1117-1120, 1981.
60. Owerbach D, and Nerup J: Restriction fragment length polymorphism of the insulin gene in diabetes mellitus. Diabetes 31: 275-277, 1982.
61. Rotwein PS, Chirgwin J, Province M, Knowler WC, Pettitt DJ, Cordell B, Goodman HM, and Permut MA: Polymorphism of the 5′ flanking region of the human insulin gene: a genetic marker for non-insulin-dependent diabetes. N Engl J Med 308: 65-71, 1983.
62. Bell GI, Horita S, and Karam JH: A polymorphic locus near the human insulin gene is associated with insulin-dependent diabetes mellitus. Diabetes 33: 176-183, 1984.
63. Hitman GA, Tarn AC, Winter RM, Drummond V, Williams LG, Jowett NI, Bottazzo GF, and Galton DJ. Type 1 (insulin-dependent) diabetes and a highly variable locus close to the insulin gene on chromosome 11. Diabetologia 28: 218-222, 1985.
64. Awata T, Shibasaki Y, Hirai H, Okabe T, Kanazawa Y, and Takaku F. Restriction fragment length polymorphism of the insulin gene region in Japanese diabetic and nondiabetic subjects. Diabetologia 28: 911-913, 1985.
65. Takeda J, Seino Y, Fukumoto H et al: The polymorphism linked to the human insulin gene: its lack of association with either IDDM or NIDDM in Japanese. Acta Endocrinol 113: 268-271, 1986.
66. Matsumoto C, Awata T, Iwamoto Y, Kuzuya T, Saito T, and Kanazawa Y: Lack of association of the insulin gene region with type 1 (insulin-dependent) diabetes mellitus in Japanese subjects. Diabetologia 37: 210-213, 1994.
67. Spies T, Bresnahan M, Bahram S, Arnold D, Blanck G, Mellins E, Pious D, and DeMars R: A gene in the human major histocompatibility complex class II region controlling the class I antigen presentation pathway. Nature 348: 744-747, 1990.
68. Spies T, and DeMars R: Restored expression of major histocompatibility class I molecules by gene transfer of a putative peptide transporter. Nature 351: 323-324, 1991.
69. Powis SH, Mockridge I, Kelly A, Kerr LA, Glynne R, Gilradi Y, Beck S, and Trowsdale J: Polymorphism in a second ABC transporter gene located within the class II region of the human major histocompatibility complex. Proc Natl Acad Sci USA 89: 1463-1467, 1992.
70. Colonna M, Bresnahan M, Bahran S, Strominger J, and Spies T: Allelic variants of the human putative peptide transporter involved in antigen processing. Proc Natl Acad Sci USA 89: 3932-3936, 1992.
71. Caillat-Zucman S, Bertin E, Timsit J, Boitard C, Assan R, and Bach JF: Protection from insulin-dependent diabetes mellitus is linked to a peptide transporter gene. Eur J Immunol 23: 1784-1788, 1993.
72. Rønningen KS, Undlien DE, Ploski R, Maouni N, Konrad RJ, Jensen E, Homes E, Reijonen H, Colonna M, Monos DS, Strominger JL, and Thorsby E: Linkage disequilibrium between TAP2 variants and HLA class II alleles: no primary association between TAP2 variants and insulin-dependent diabetes mellitus. Eur J Immunol 23: 1050-1056, 1993.
73. Nakanishi K, Kobayashi T, Murase T, and Kosaka K: Lack of association of the transporter associated with antigen processing with Japanese insulin-dependent diabetes mellitus. Metabolism 43: 1013-1017, 1994.
74. Vanbuskrk A, Crump BL, Margoliash E, and Pierce AK: A peptide binding protein having a role in antigen presentation is a member of the HSP70 heat shock family. J Exp Med 170: 1799-1899, 1989.
75. Polla BS, and Young D: Heat shock proteins and immunity. Immunol Today 10: 393-394, 1989.
76. Kaufmann SHE: Heat shock proteins and the immune response. Immunol Today 11: 129-136, 1990.
77. Harrison GS, Drabkin HA, and Kao FT: Chromosomal location of human genes encoding major heat-shock protein HSP70. Somatic Cell Mol Genet 13: 119-130, 1987.
78. Goate AM, Cooper DN, Hall C, Leung TKC, Solomon E, and Lim L: Localization of a human heat-shock HSP70 gene sequence to chromosome 6 and detection of two other loci by somatic-cell hybrid and restriction fragment length polymorphism analysis. Hum Genet 75: 123-128, 1987.
79. Sargent CA, Dunham I, Trowsdale J, and Campbell RD: Human major histocompatibility complex contains genes for the major heat shock protein HSP70. Proc Natl Acad Sci USA 86, 1968-1972, 1989.
80. Milner CM, and Campbell RD: Structure and expression of the three MHC-linked HSP70 genes. Immunogenetics 32: 242-251, 1990.
81. Caplan NJ, Patel A, Millward A, Campbell RD, Ratanachaiyavong S, Wong FS, and Demaine AG. Complement C4 and heat shock protein 70 (HSP70) genotype and type 1 diabetes mellitus. Immunogenetics 32: 427-430, 1990.
82. Kawaguchi Y, Ikegami H, Fukuda Y, Fujioka Y, Shima K, and Ogihara T: Polymorphism of HSP 70 gene is not associated with type 1 (insulin-dependent) diabetes mellitus in Japanese. Diabetes Res Clin Pract 21: 103-107, 1993.
83. Pugliese A, Awdeh ZL, Galluzzo A, Yunis EJ, Apler CA, and Eisenbatrh GS: No independent association between HSP70 gene polymorphism and IDDM. Diabetes 41: 788-791, 1992.
84. Rabinovitch A: Roles of cytokines in IDDM pathogenesis and islet β-cell destruction. Diabetes Rev 1: 215-240, 1993.
85. Mandrup-Pulsen T, Bendtzen K, Dinarello CA, and Nerup J: Human tumor necrosis factor potentiates human interleukin 1-mediated rat pancreatic β-cell cytotoxicity. J Immunol 12: 4077-4082, 1987.
86. Puhel C, Baquerizo H, and Rabinovitch A: Destruction of rat islet monolayers by cytokeres: synergistic interactions of interferon-gamma, tumor necrosis factor, lymphotoxin and interleukin-1. Diabetes 37: 133-136, 1988.
87. Campbell IL, Oxbrow L, West J, and Harrison LC: Reguration of MHC protein expression in pancreatic β-cells by interferon-γ and tumor necrosis factor-α. Mol Endocrinol 2: 101-107, 1988.
88. Pujol-Borrell R, Todd I, Doshi M, Bottazzo GF, Sutton R, Gray D, Adolf GR, and Feldmann M: HLA class II induction in human islet cells by interferon-gamma plus tumor necrosis factor or lymphotoxin. Nature 326: 304-306, 1987.
89. Campbell IL, Cutri A, Wilkinson D, Boyd AW, and Harrison LC: Intercellular adhesion molecule-1 is induced on endocrine islet cells by cytokines but not by reovirus infection. Proc Natl Acad Sci USA 85: 4282-4286, 1989.
90. Pukel C, Baquerizo H, and Rabinovitch A: Destruction of rat islet cell monolayers by cytokines: synergistic interactions of interferon-γ, tumor necrosis factor, lymphotoxin, and interleukin 1. Diabetes 37: 133-136, 1988.
91. Campbell IL, Iscaro A, and Harrison LC: INF-γ and tumor necrosis factor-α. Cytoxicity to murine islets of Langerhans. J Immunol 141: 2325-2329, 1988.
92. Rabinovitch A, Sumoski W, Rajotte RV, and Warnock GL: Cytotoxic effects of cytokines on human pancreatic islet cells in monolayer culture. J Clin Endocrinol Metab 71: 151-156, 1990.
93. Arai K, Lee F, Miyajima A, Miyatake S, Arai N, and Yokota T: Cytokines: coordinators of immune and inflammatory responses. Annu Rev Biochem 59: 783-836, 1990.
94. Whcher JT, and Evans SW: Cytokines in disease. Clin Chem 36: 1269-1281, 1990.
95. Badenhoop K, Schwartz G, Trowsdale J, Lewis V, Usadel KH, Gale EAM, and Bottazzo GF: TNFα gene polymorphisms in type 1 (insulin-dependent) diabetes mellitus. Diabetologia 32: 445-148, 1989.
96. Pociot F, Molvig J, Wogensen H, Worsaae H, Dalboege H, Baek L, and Nerup J: A tumour necrosis factor beta gene polymorphism in relation to monokine secretion and insulin-dependent diabetes mellitus. Scand J Immunol 33: 37-41, 1991.
97. Vendrell J, Ercilla G, Gutierrez C, Gomis R, Goday A, Fernandez J, Richart C, and Vilardell E: A tumor necrosis factor β-gene polymorphism associated with islet cell antibodies in newly diagnosed type 1 diabetic patients. Diabetes Care 17: 944-945, 1994.
98. Gray PW, and Goeddel DV: Structure of the human immune interferon gene. Nature 298: 859-863, 1982.
99. Awata T, Matsumoto C, Urakami T, Hagura R, Amemiya S, and Kanazawa Y: Association polymorphism in the interferon γ gene with IDDM. Diabetologia 37: 1159-1162, 1994.
100. Kobayashi T, Itoh T, Kosaka K, Sato K, and Tsuji K: Time course of islet cell antibodies and β cell function in non-insulin-dependent stage of type 1 diabetes. Diabetes 36: 510-517, 1987.
101. Kadowaki T, Miyake Y, Hagura R, Akanuma Y, Kajinuma H, Kuzuya N, Takaku F, and Kosaka K: Risk factors for worsening to diabetes in subjects with impaired glucose tolerance. Diabetologia 26: 44-49, 1984.
102. Ungar B, Stocks A, Martin F, Whittingham S, and Mackay S: Intrinsic factor antibody parietal cell antibody and latent pernicious anemia in diabetes mellitus. Lancet ii: 415-417, 1968.
103. Landing BH, Pettit MD, Wiens RL, Knowles H, and Guest DM: Antithyroid antibody and chronic thyroiditis in diabetes. J Clin Endocrinol Metab 23: 119-120, 1963.
104. Irvine WJ, Clarke BF, Scarth L, Cullen DL, and Duncan LJP: Thyroid and gastric autoimmunity in patients with diabetes mellitus. Lancet ii: 163-168, 1970.
105. Fialkow PJ, Zavala C, and Nielsen R: Thyroid autoimmunity: increased frequency in relatives of insulin-dependent diabetes patients. Ann Intern Med 83: 170-176, 1975.
106. Riley WJ, MacLaren NK, Lezotte DC, Spillar RP, and Rosenbloom AR: Thyroid autoimmunity in insulin-dependent diabetes mellitus: the case for routine screening. J Pediatr 98: 350-354, 1981.
107. Goldstein DE, Drash A, Gibbs J, and Blizzard RM: Diabetes mellitus: the incidence of circulatory antibodies against thyroid, gastric and adrenal tissue. J Pediatr 77: 304-306, 1970.
108. Nerup J, and Binder C: Thyroid, gastric and adrenal autoimmunity in diabetes mellitus. Acta Endocrinol (Copenh) 72: 279-286, 1973.
109. Scherbaum WA, and Berg PA: Development of adrenocortical failure in non-Addisonian patients with antibodies to adrenal cortex: a clinical follow-up study. Clin Endocrinol 16: 345-352, 1982.
110. Betterle C, Zanette F, Pedini B, Peresotto F, Rapp LB, Monciotti CM, and Rigon F: Clinical and subclinical organ-specific autoimmune manifestations in type 1 (insulin-dependent) diabetic patients and their first-degree relatives. Diabetologia 26: 431-436, 1984.
111. Mimura G, Kida K, Matsuura N, Toyota T, Kitagawa T, Kobayashi T, Hibi I, Ikeda Y, Tsuchida I, Kuzuya H, Aono S, Doi K, Nishimukai H, Jinnouchi T, and Murakami K: Immunogenetics of early-onset insulin-dependent diabetes mellitus among Japanese: HLA, Gm, BF, GLO, and organ-specific autoantibodies: the JDS study. Diabetes Res Clin Pract 8: 253-262, 1990.
112. Akazawa S, Kawasaki E, Yano M, Abiru N, Yamaguchi Y, and Nagataki S: Autoantibodies to glutamic acid decarboxylase (GAD), 64000-Mr islet cell protein (64 K) antibodies and islet cell antibodies (ICA) in insulin-dependent diabetes mellitus with and without autoimmune diseases in Japan. Diabetes Res Clin Pract 24 (Suppl): S89-S93, 1994.
113. Eisenbarth GS: Type 1 diabetes mellitus: a chronic autoimmune disease. N Engl J Med 314: 1360-1368, 1986.
114. Bottazzo GF, Florin-Christensen A, and Doniach D: Islet cell antibodies in diabetes mellitus auto-immune polyendocrine deficiency. Lancet ii: 1279-1282, 1974.
115. MacCuish AC, Barnes EW, Irvine WJ, and Duncan IJP: Autoantibodies to pancreatic-islet cells in insulin dependent diabetics with coexistent autoimmune disease. Lancet ii: 1529-1533, 1974.
116. Lendrum R, Walker LG, and Gamble DR: Islet cell antibodies in juvenile diabetes mellitus of recent onset. Lancet i: 880-882, 1975.
117. Landin-Olsson M, Karlsson A, Dahlquist G, Blom L, Lernmark Å, and Sundkvist G: Islet cell and other organ-specific autoantibodies in all children developing type 1 (insulin-dependent) diabetes mellitus in Sweden during one year and in matched control children. Diabetologia 32: 387-395, 1989.
118. Baekkeskov S, Nielsen JH, Marner B, Bilde T, Ludvigsson J, and Lernmark Å: Autoantibodies in newly diagnosed diabetic children immunoprecipitate human pancreatic islet cell protein. Nature 298: 167-169, 1982.
119. Baekkeskov S, Dyrberg T, and Lernmark Å: Autoantibodies to the 64 kilodalton islet cell protein precede the onset of spontaneous diabetes in the BB rat. Science 224: 1348-1348, 1988.
120. Atkinson MA, and Maclaren NK: Autoantibodies in NOD mice immunoprecipitate an 64,000 Mr islet cell antigen. Diabetes 37: 1587-1590, 1988.
121. Baekkeskov S, Landin M, Kristensen JK, Srikanta S, Bruining GJ, Mandrup-Poulsen T, De Beaufortt C, Soeldner JS, Eisenbarth G, Lindgren F, Sundqvist G, and Lernmark Å: Antibodies to a 64000 Mr human islet cell protein precede the clinical onset of insulin-dependent diabetes. J Clin Invest 79: 926-934, 1987.
122. Atkinson MA, Maclaren NK, Scharp DW, Lacy PE, and Riley WJ: 64000 Mr autoantibodies as predictors of insulin-dependent diabetes. Lancet 35: 1357-1360, 1990.
123. Christie M, Landin-Olsson M, Sundkvist G, Dahlquist G, Lernmark Å, and Baekkeskov S: Antibodies to a Mr 64,000 islet cell protein in Swedish children with newly diagnosed type 1 (insulin-dependent) diabetes. Diabetologia 31: 597-602, 1988.
124. Baekkeskov S, Aanstoot HJ, Christgau S, Reetz A, Solimena M, Cascalho M, Folli F, Richter-Olesen H, and De Camilli P: Identification of the 64 K autoantigen in insulin-dependent diabetes as the GABA-synthesizing enzyme glutamic acid decarboxylases. Nature 347: 151-156, 1990.
125. Solimena M, Folli F, Denis-Donini S, Comi GC, Pozza G, De Camilli P, and Vicari AM: Autoantibodies to glutamic acid decarboxylase in a patient with stiff-man syndrome, epilepsy, and type 1 diabetes mellitus. N Engl J Med 318: 1012-1020, 1988.
126. Solimena M, Folli F, Aparisi R, Pozza G, and De Camilli P: Autoantibodies to GABA-ergic neurons and pancreatic beta cells in stiff-man syndrome. N Engl J Med 322: 1555-1560, 1990.
127. Michelsen BK, Petersen JS, Boel E, Moldrup A, Dyrberg T, and Madsen OD: Cloning, characterization, and autoimmune recognition of rat islet glutamic acid decarboxylase in insulin-dependent diabetes mellitus. Proc Natl Acad Sci USA 88: 8754-8758, 1991.
128. Karlsen AE, Hagopian WA, Grubin CE, Dube S, Disteshe CM, Adle DA, Bärmeier H, Mathewes S, Grant FJ, Foster D, and Lernmark Å: Cloning and primary structure of a human islet isoform of glutamic acid decarboxylase from chromosome 10. Proc Natl Acad Sci USA 88: 8337-8341, 1991.
129. Erlander MG, Tillakaratne NJ, Feldblum S, Patel N, and Tobin AJ: Two genes encode distinct glutamate decarboxylases. Neuron 7: 91-100, 1991.
130. Bu DF, Erlander MG, Hits BC, Tillakaratne NJK, Kaufman DL, Wagner-McPherson CB, Evans GA, and Tobin AJ: Two human glutamate decarboxylases, 65-kDa GAD and 67-kDa GAD, are each encoded by a single gene. Proc Natl Acad Sci USA 89: 2115-2119, 1992.
131. Hagopian WA, Karlsen AE, Gottsater A, Landin-Olsson M, Grubin CE, Sundkvist G, Petersen JS, Boel E, Dyrberg T, and Lernmark Å: Quantitative assay using recombinant human islet glutamic acid decarboxylase (GAD 65) shows that 64 K autoantibodies positivity at onset predicts diabetes type. J Clin Invest 91: 368-374, 1993.
132. Karlsen AE, Hagopian WA, Petersen JS, Boel E, Dyrberg T, Grubin CE, Michelsen BK, Madsen OD, and Lernmark Å: Recombinant glutamic acid decarboxylase (representing the single isoform expressed in human islets) detects IDDM-associated 64,000-Mr autoantibodies. Diabetes 41: 1355-1359, 1992.
133. Hagopian WA, Michelsen B, Karsen AE, Larsen F, Moody A, Grubin CE, Rowe R, Petersen JS, McEvoy R, and Lernmark Å: Autoantibodies in IDDM primarily recognize the 65,000-Mr rather than the 67,000-Mr isoform of glutamic acid decarboxylase. Diabetes 42: 631-636, 1993.
134. Martino GV, Tappaz ML, Braghi L, Dozio N, Canal N, Pozza G, Bottazzo GF, Grimaldi LME, and Bosi E: Autoantibodies to glutamic acid decarboxylase (GAD) detected by an immunotrapping enzyme activity assay: relation to insulin-dependent diabetes mellitus and islet cell antibodies. Autoimmunity 4: 915-923, 1991.
135. Rowley MJ, Mackay IR, Chen QY, Knowles WJ, and Zimmet PZ: Antibodies to glutamic acid decarboxylase discriminate major types of diabetes mellitus. Diabetes 41: 548-551, 1992.
136. Kawasaki E, Takino H, Yano M, Uotani S, Matsumoto K, Takao Y, Yamaguchi Y, Akazawa S, and Nagataki S: Autoantibodies to glutamic acid decarboxylase in patients with IDDM and autoimmune thyroid disease. Diabetes 43: 80-86, 1994.
137. Thivolet CH, Tappaz M, Durand A, Petersen JS, Stefanutti A, Chatelain P, Vialettes B, Scher- baum W, and Orgiazzi J: Glutamic acid decarboxylase (GAD) autoantibodies are additional predictive markers of type 1 (insulin-dependent) diabetes mellitus in high risk individuals. Diabetologia 35: 570-576, 1992.
138. De Aizpurua HJ, Harrison LC, and Cram DS: An ELISA for antibodies to recombinant glutamic acid decarboxylase in IDDM. Diabetes 41: 182-187, 1992.
139. De Aizpurua HJ, Wilson YM, and Harrison LC: Glutamic acid decarboxylase autoantibodies in preclinical insulin-dependent diabetes. Proc Natl Acad Sci USA 89: 9841-9845, 1992.
140. Kaufman DL, Erlander MG, Clare-Salzler M, Atkinson MA, Maclaren N, and Tobin AJ: Autoimmunity to two forms of glutamate decarboxylase in insulin-dependent mellitus. J Clin Invest 89: 283-292, 1992.
141. Schmidli RS, Colman PG, Bonifacio E, Bottazzo GF, Harrison LC, and participating laboratories: High level of concordance between assays for glutamic acid decarboxylase antibodies: the first international glutamic acid decarboxylase antibody workshop. Diabetes 43: 1005-1009, 1994.
142. Schmidli RS, Colman PG, Bonifacio E, and participating laboratories: Disease sensitivity and specificity of 52 assays for glutamic acid decarboxylase antibodies: the second international GADAb workshop. Diabetes 44: 636-640, 1995.
143. Irvine W: Immunological aspects of diabetes mellitus. In Immunology of Diabetes, Irvine WJ (Ed). Teviot Scientific Publications, Edinburgh, 1980, pp 1-53.
144. Sakurami T, Nagaoka N, Nabeya Y, Ueno H, Imura H, and Kuno S: HLA specificities and islet cell antibodies in Japanese insulin-dependent diabetics. In Genetic Environmental Interaction in Diabetes Mellitus, Hanna M, and Baba S (Eds). Excerpta Medica, Amsterdam, 1982, pp 155-160.
145. Takahashi A, Tsujihata M, Yokota A, Yamaguchi Y, Ueda Y, Akazawa S, Miyake S, and Nagataki S: A new method of detection of islet cell antibodies (ICA) using peroxidase-labeled protein A, and incidence of ICA in type 1 (insulin-dependent) diabetes. Diabetologia 29: 378-382, 1986.
146. Kawasaki E, Takino H, Yano M, Uotani S, Matsumoto K, Yamaguchi Y, Akazawa S, and Nagataki S: Evaluation of islet-specific autoantibodies in Japanese patients with insulin-dependent diabetes mellitus: a comparison between autoantibodies to glutamic acid decarboxylase, autoantibodies to 64 kDa islet cell protein and islet cell antibodies. J Autoimmun 7: 791-802, 1994.
147. Kobayashi T, Sugimoto T, Itho T, Kosaka K, Tanaka T, Suwa S, Sato K, and Tsuji K: The prevalence of islet cell antibodies in Japanese insulin-dependent and non-insulin-dependent diabetic patients studies by indirect immunofluorescence and by a new method. Diabetes 35: 335-340, 1986.
148. Urakami T, Miyamoto Y, Matsunaga H, Owada M, and Kitagawa T: Serial changes in the prevalence of islet cell antibodies and islet cell antibody titer in children with IDDM of abrupt or slow onset. Diabetes Care 18: 1095-1099, 1995.
149. Yano M, Moriuchi R, Kawasaki E, Watanabe M, Saito K, Takino H, Akazawa S, Miyamoto T, and Nagataki S: Autoantibodies against glutamic acid decarboxylase 65 in Japanese patients with insulin-dependent diabetes mellitus (IDDM). J Autoimmun 8: 83-96, 1995.
150. Genovese S, Bonifacio E, McNally JM, Dean BM, Wagner R, Bosi E, Gale EAM, and Bottazzo GF: Distinct cytoplasmic islet cell antibodies with different risks for type 1 (insulin-dependent) diabetes mellitus. Diabetologia 35: 385-388, 1992.
151. Gianani R, Pugliese A, Bonner-Weir S, Shiffrin AJ, Soeldner JS, Erlich H, Awdeh Z, Alper CA, Jackson RA, and Eisenbarth GS: Prognostically significant heterogeneity of cytoplasmic islet cell antibodies in relatives of patients with type 1 diabetes. Diabetes 41: 347-352, 1992.
152. Kobayashi T, Nakanishi K, Murase T, and Kosaka K: Subtype of islet cell antibodies and slowly progressive beta-cell failure. Diabetologia 36: 92, 1993.
153. Takino H, Kawasaki E, Yano M, Matsumoto K, Okuno S, Takao Y, Yamasaki H, Yamaguchi Y, Akazawa S, and Nagataki S: The heterogeneity of whole islet cell cytoplasmic antibodies evidenced by absorption test with glutamic acid decarboxylase. J Autoimmun 7: 389-398, 1994.
154. Katagiri H, Asano T, Ishihara H, Inukai K, Anai M, Miyazaki J, Tsukuda K, Kikuchi M, Yazaki Y, and Oka Y: Non-sense mutation of glucokinase gene in late-onset non-insulin-dependent diabetes mellitus. Lancet 340: 1316-1317, 1992.
155. Kadowaki T, Kadowaki H, Mori Y, Tobe K, Sakuta R, Suzuki Y, Tanabe Y, Sakura H, Awata T, Goto Y, Hayakawa T, Matsuoka K, Kawamori R, Kamada T, Horai S, Nonaka I, Hagura R, Akanuma Y, and Yazaki Y: A subtype of diabetes mellitus associated with a mutation of mitochondrial DNA. N Engl J Med 330: 962-968, 1994.
156. Groop LC, Miettinen A, Groop P, Meri S, Koskimies S, and Bottazzo GF: Organ-specific autoimmunity and HLA-DR antigens as markers for β-cell destruction in patients with type II diabetes. Diabetes 37: 99-103, 1988.
157. Groop LC, Bottazzo GF, and Doniach D: Islet cell antibodies identify
158. Kobayashi T, Tanemoto K, Nakanishi K, Kato N, Okubo M, Kajio H, Sugimoto T, Murase T, and Kosaka K: Immunogenetic and clinical characterization of slowly progressive IDDM. Metabolism 16: 780-788, 1993.
159. Tuomi T, Groop LC, Zimmet PZ, Rowley MJ, Knowles W, and Mackay IR: Antibodies to glutamic acid decarboxylase reveal latent autoimmune diabetes mellitus in adults with a non-insulin-dependent onset of disease. Diabetes 42: 359-362, 1993.
160. Zimmet PZ, Tuomi T, Mackay IR, Rowley MJ, Knowles W, Cohen M, and Lang DA: Latent autoimmune diabetes mellitus in adults (LADA): the role of antibodies to glutamic acid decarboxylase in diagnosis and prediction of insulin dependency. Diabetic Med 29: 299-303, 1993.
161. Niskanen LK, Tuomi T, Karjalainen J, Groop LC, and Uusitupa MIJ: GAD antibodies in NIDDM: ten-year follow-up from the diagnosis. Diabetes Care 18: 1557-1565, 1995.
162. Nagataki S: Type 1 diabetes in Japan. In Current status of diabetes melitus in East Asia, Mimura G, Qian RL, and Murakami K (Eds). Excerpta Medica, Amsterdam, 1994, pp 19-24.
163. Vardi P, Crisa L, Jackson RA, Herskowitz RD, Wolfsdorf JI, Einhorn D, Linarelli L, Dolinar R, Wentworth S, Brink SJ, Starkman H, Soeldner JS, and Eisenbarth GS: Predictive value of intravenous glucose tolerance test insulin secretion less than or greater than the first percentile in islet cell antibody positive relatives of type 1 (insulin-dependent) diabetic patients. Diabetologia 34: 93-102, 1991.
164. Bingley PJ, Christie MR, Bonifacio E, Bonfanti R, Shattock M, Fonte MT, Bottazzo GF, and Gale EAM: Combined analysis of autoantibodies improves prediction of IDDM in islet cell antibody-positive relatives. Diabetes 43: 1304-1310, 1994.
165. Matsuda A, and Kuzuya T: Diabetic twins in Japan. Diabetes Res Clin Pract 24 (Suppl): S63-S67, 1994.
166. Kumar D, Gematel NS, Deapen D, Kapadia D, Yamashita PH, Lee M, Dwyer JH, Roy-Burman P, Bray GA, and Mack TM: North-American twins with IDDM: genetic, etiological, and clinical significance of disease concordance according to age, zygosity, and the interval after diagnosis in first twin. Diabetes 42: 1351-1363, 1993.
167. Kaprio J, Tuomilehto J, Koskenvuo M, Romanov K, Reunanen A, Eriksson J, Stengård J, and Kesäniemi YA: Concordance for type 1 (insulin-dependent) and type 2 (non-insulin-dependent) diabetes mellitus in a population-based cohort of twins in Finland. Diabetologia 35: 1060-1067, 1992.
168. Olmos P, A'Hern R, Heaton DA, Millward BA, Risley D, Pyke DA, and Leslie RDG: The significance of the concordance rate for type 1 (insulin-dependent) diabetes in identical twins. Diabetologia 31: 747-750, 1988.